Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ace-ER Extension in GNE Myopathy
NCT02736188Phase 3Terminated
- Sponsor
- Ultragenyx Pharmaceutical Inc.
- Start
- May 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of aceneuramic acid in GNE myopathy (HIBM), sponsored by Ultragenyx Pharmaceutical Inc.. Started May 2016; status: terminated.
02
Drugs
aceneuramic acid
03
Conditions
GNE myopathy (HIBM)
Beyond the preview
Go deeper on NCT02736188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736188.